With reference to Section 30 of the Danish Capital Markets Act,Nilfisk Holding A/S has been informed by Boldhaven Management LLP that Boldhaven Management LLP as of April 15,2026,has decreased its tot
The proceeds will support the advancement of STC-15 in a Phase 2 study in select sarcoma indicationsFirst‑in‑class METTL3 inhibitor reprograms malignant progenitor cells by modulating mRNA methylati
Press contact: Elsa Estager Bergerou Tel.: +33 6 59 62 55 13 E-mail: elsa.estager-bergerou@capgemini.com
23,Place des Carmes-Déchaux - 63000 CLERMONT-FERRAND Information about securities repurchasing program
TME Pharma Announces Publication of NOX-A12 “Triple Therapy” Phase 1/2 Expansion Arm A Findings from GLORIA trial in Nature Communications
Fiocchi,part of the CSG,has introduced a new generation of counter-drone ammunition designed to enable soldiers to effectively engage small unmanned aerial vehicles (UAVs) using standard-issue firearm
LONDON,April16,2026(GLOBE NEWSWIRE) -- Kleene.ai,the AI-native data platform for mid-market and enterprise brands,today launched KAI Assistant — enabling data teams and business users to write SQL,de
Nokia and Cinia partner to secure Finland’s critical infrastructure with advanced DDoS protection Cinia deploying Nokia advanced Distributed Denial of Service (DDoS) protection solution to safeguard
23,Place des Carmes-Déchaux - 63000 CLERMONT-FERRAND Informations sur les opérations réalisées dans le cadre d’un programme de rachat d’actions,hors contrat de liquidité
Contact presse : Elsa Estager Bergerou Tél : +33 6 59 62 55 13 Email : elsa.estager-bergerou@capgemini.com
微信扫一扫 立即联系我们
简体中文
